ProAssurance reported an operating loss of $0.60/share in Q2 2020, a significant loss at a negative 5% ROE but one that was expected by the Street with consensus at a loss of $0.74/share.
The
ProAssurance highlights rate gains in medmal in spite of big Q2 loss